Hippocratic AI Secures $126 Mn in Series C funding, Soaring its Valuation to $3.5 Bn.

With the new investment, the company aims to scale customer deployments worldwide, enhance its Polaris Safety Constellation Architecture, accelerate product innovation, and evaluate strategic mergers and acquisitions.

Hippocratic AI, a healthcare-focused artificial-intelligence company, has announced its recent Series C funding of $126 million, elevating its valuation to $3.5 billion.

The funding round was led by Avenir Growth with participation from investors such as CapitalG, Andreessen Horowitz, General Catalyst, Kleiner Perkins, and several major health systems, including Universal Health Services and Cincinnati Children’s Hospital Medical Center.

Commenting on the investment, Andrew Sugrue, co-founder of Avenir Growth, said, “We believe Hippocratic AI is leading the agentic healthcare category. Importantly, we found that their relentless focus on safety has earned them the trust of healthcare organisations around the world, becoming the safe choice for executives when choosing AI agents for deployment in healthcare.”

Founded in 2024, Hippocratic AI is set to develop what it calls the world’s first large language model built specifically for healthcare, with an initial focus on non-diagnostic, patient-facing use cases. Its AI agents are designed to handle clinically important tasks such as patient intake, post-visit follow-ups, medication adherence support, chronic care outreach, and post-discharge monitoring.

In June last year, the company launched its first commercial product, a generative AI-powered, task-specific healthcare agent. Since then, Hippocratic AI has partnered with more than 50 health systems, payers, and pharmaceutical organizations across six countries, completing over 115 million patient interactions with no reported safety issues.

With the new investment, the company aims to scale customer deployments worldwide, enhance its Polaris Safety Constellation Architecture, accelerate product innovation, and evaluate strategic mergers and acquisitions.

"What this capital allows us to do is touch more lives and help more people while staying true to our core values of 'do no harm' and 'patients first,'" said Munjal Shah, co-founder and CEO of Hippocratic AI.

"We truly believe that Generative AI agents can help bring in an era of abundance to healthcare never seen before," he added.

Stay tuned for more such updates on Digital Health News